CD133+ Cell Therapy for Refractory Coronary Heart Disease
Intramyocardial Delivery of Autologous Bone Marrow
A Prospective, Open, Non-randomized Phase I/II Study of Therapeutic Angiogenesis in Diabetic Patients With Critic Ischemia of Lower Limbs While Administering Positive CD133 Mobilized With G-CSF
Intracoronary Autologous Stem Cell Transplantation in ST Elevation Myocardial Infarction: TRACIA STUDY.
† Indicates status has not been verified in more than two years